IP Library Granted Patent US 7,976,874
Granted Patent B2
US 7,976,874 · App. 11/129,029 · Granted Jul 12, 2011

Injectable calcium phosphate cements and the preparation and use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,976,874
App. No.
11/129,029
Granted
Jul 12, 2011
Kind
B2
Abstract

A calcium phosphate cement suitable for use in dental and bone prosthesis is disclosed, which include calcium phosphate particles having a diameter of 0.05 to 100 microns, wherein said calcium phosphate particles on their surfaces have whiskers or fine crystals having a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm.

Claims (16)

1. A method of repairing a defect or a cavity in a bone or a tooth comprising:

forming a non-dispersive, injectable calcium phosphate cement paste by contacting calcium phosphate cement particles with an aqueous solution comprising a hardening-promoter; and

injecting the paste into the defect or the cavity in the bone or tooth;

wherein the diameter of the calcium phosphate cement particles is from 0.05 microns to 100 microns, wherein at least a portion of the calcium phosphate particles have surface crystals comprising basic calcium phosphate crystals, and wherein the surface crystals have a width ranging from 1 nm to 100 nm and a length ranging from 1 to 1000 nm.

2. The method of claim 1 , wherein the calcium phosphate cement particles comprise calcium dihydrogen phosphate, calcium dihydrogen phosphate hydrate, acid calcium pyrophosphate, anhydrous calcium hydrogen phosphate, tetracalcium phosphate, calcium hydrogen phosphate hydrate, calcium pyrophosphate, calcium triphosphate, calcium polyphosphate, calcium metaphosphate, anhydrous tricalcium phosphate, tricalcium phosphate hydrate, apatite, hydroxyapatite, or mixtures thereof.

3. The method of claim 1 , wherein the calcium phosphate cement particles comprise dicalcium phosphate anhydrous, tetracalcium phosphate, tricalcium phosphate, or mixtures thereof.

4. The method of claim 1 , wherein the paste further comprises a growth factor, a bone morphology protein, a pharmaceutical carrier, or mixtures thereof.

5. The method of claim 1 , wherein the hardening-promoter comprises phosphate ions, calcium ions, fluorine ions, or mixtures thereof.

6. The method of claim 1 , wherein the aqueous solution comprises 1 mM to 3 M of the hardening promoter.

7. The method of claim 1 , wherein hardening-promoter comprises phosphate ions.

8. The method of claim 1 , wherein the pH of the aqueous solution is 6.0.

9. The method of claim 1 , wherein the calcium phosphate cement particles have a diameter ranging from 0.5 microns to 50 microns.

10. The method of claim 1 , wherein the crystals have a length ranging from 10 nm to 700 nm.

11. The method of claim 1 , wherein the calcium phosphate cement particles have a calcium to phosphate molar ratio ranging from 0.5 to 2.5.

12. The method of claim 1 , wherein the calcium phosphate cement particles have a calcium to phosphate molar ratio ranging from 0.8 to 2.3.

13. The method of claim 1 , wherein the calcium phosphate cement particles have a calcium to phosphate molar ratio ranging from 1.0to 2.2.

Assignments (15)
RELEASE OF SECURITY INTEREST Recorded Aug 29, 2022
From: BANKUNITED, N.A.
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 061333/0853 →
SECURITY INTEREST Recorded Aug 4, 2022
From: VIVEX BIOLOGICS GROUP, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 061084/0607 →
RELEASE OF SECURITY INTEREST Recorded Dec 12, 2019
From: HERITAGE BANK OF COMMERCE
To: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
Reel/Frame 051282/0653 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Dec 11, 2019
From: VIVEX BIOLOGICS GROUP, INC.
To: BANKUNITED, N.A.
Reel/Frame 051260/0064 →
CHANGE OF NAME Recorded Aug 16, 2019
From: VIVEX BIOMEDICAL, INC.
To: VIVEX BIOLOGICS, INC.
Reel/Frame 050079/0179 →
CHANGE OF NAME Recorded Aug 16, 2019
From: VIVEX BIOLOGICS, INC.
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 050079/0225 →
RELEASE OF SECURITY INTEREST Recorded Mar 28, 2017
From: SILICON VALLEY BANK
To: VIVEX BIOMEDICAL, INC.
Reel/Frame 042103/0686 →
SECURITY INTEREST Recorded Feb 22, 2017
From: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC.; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 041782/0452 →
SECURITY INTEREST Recorded Jan 5, 2016
From: VIVEX BIOMEDICAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 037413/0089 →
RELEASE OF SECURITY INTEREST Recorded Sep 18, 2014
From: JPMORGAN CHASE BANK, N.A.
To: AMENDIA, INC.
Reel/Frame 033771/0759 →
SECURITY INTEREST Recorded Jun 10, 2014
From: AMENDIA, INC.
To: JP MORGAN CHASE BANK NA
Reel/Frame 033120/0286 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2014
From: AMENDIA, INC.
To: VIVEX BIOMEDICAL, INC.
Reel/Frame 032454/0287 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2012
From: OSTEOTHERAPEUTICS, LLC
To: AMENDIA, INC.
Reel/Frame 028376/0199 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2005
From: CANA LAB CORPORATION
To: CALCITEC, INC.
Reel/Frame 016900/0517 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2005
From: LIN, JIIN-HUEY CHERN; JU, CHIEN-PING; CHEN, WEN-CHEN
To: CANA LAB CORPORATION
Reel/Frame 016900/0865 →